Studienserver - Medizinische Hochschule Hannover

Studies: Everolimus in patients with metastatic RCC after VEGF-targeted therapy failure

ID Trial

MARC-2

EudraCT number

2010-021370-11

Clinicaltrials.gov identifier

NCT01266837

Description

An open label, single arm trial to characterize patients with metastatic renal cell carcinoma treated with everolimus after failure of the first VEGF-targeted therapy

Status

active